Biopharma | May 18, 2026
Kotak Alts invests Rs. 200 million in Cellogen Therapeutics
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Subscribe To Our Newsletter & Stay Updated